Glenmede Trust CO Na Royalty Pharma PLC Call Options Transaction History
Glenmede Trust CO Na
- $20.6 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RPRX
# of Institutions
410Shares Held
284MCall Options Held
499KPut Options Held
47.5K-
Morgan Stanley New York, NY41.1MShares$1.05 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.6MShares$961 Million0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$589 Million0.01% of portfolio
-
Baillie Gifford & CO16.1MShares$412 Million0.35% of portfolio
-
Viking Global Investors LP12.1MShares$309 Million1.32% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $11.2B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...